LFSTLifeStance Health Group, Inc.
Is it safe?
Forensics clean, with a caveat: a safe balance sheet and comfortable debt (AA), but big price swings.
Financially healthy, low distress risk Altman Z-score, a bankruptcy-risk model from five balance-sheet ratios.
Insiders were net sellers (-$378.8M, 90 days to Oct 8, 2026), selling is often routine.
Rock-solid balance sheet, low leverage. A rule of thumb on leverage, not a credit rating.
Large price swings, high volatility. Worst drawdown -87% · now 7% below its 52-week high.
Unless marked, from SEC EDGAR, as of Dec 31, 2025.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Altman sits structurally low for utilities and pipelines; Beneish runs high for fast growers, since sales growth alone lifts it; banks and REITs are excluded.
Can LFST take a bad year?
LifeStance Health Group, Inc. carries $48M of net debt at 0.39× EBITDA: a load its earnings can carry.
Net debt · as at Q2 2026 · under two and a half years of EBITDA, comfortable
- Net debt / EBITDA
- 0.39×
Net debt / EBITDA · 2.30× a year ago · the load is coming down
- Altman Z-score
- 3.57
Altman Z-score · safe zone, above 3
- Interest cover
- 7.75×
Interest cover · operating profit covers the interest bill several times over
Details›
- Total debtQ2 2026
- $273M
- Cash and short-term investments
- $226M
- Net debt
- $48M
- EBITDA, trailing twelve months
- $121M
- Operating profit, trailing twelve months
- $78M
- Debt / equity
- 0.18×
- Total debt / EBITDA
- 2.26×
- Annualised volatilitytwo years of daily moves
- 49%
- Worst drawdown on file
- −87%
- Below its 52-week high
- 7.2%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.
Medical Care Facilities
Ranks #20 of 27 by RyuScore